| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Dale Broadrick last filed a Form 4 in October 2024, as 10% Owner at BRTX. Dale Broadrick's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Dale Broadrick a middling insider score of 60/100, based on 45 past trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +3.4%.
At the last filing, the largest reported position was 445,933 shares of BRTX. Net of sales, the BRTX filings show accumulation of 16,782,982 shares.
Dale Broadrick has 32 Form 4 filings on record from February 2019 to October 2024, all as 10% Owner at BioRestorative Therapies (BRTX), 2019–2024.
The 129 reported transactions were 107 open-market purchases, 18 other transactions and 4 open-market sales.
Counted by filing, the open-market trades come to 29 purchases worth about $3.3M and 4 sales worth about $10K.
The largest open-market purchase was 155,950 shares of BRTX at an average $5.09 on March 21, 2022, about $794K. Twelve months later BRTX was down 27%.
The largest open-market sale was 2,000 shares of BRTX at an average $3.44 on May 26, 2022, about $7K. Twelve months later BRTX was up 63%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Sell | 1,112 | $1.58 | $1,756.96 | -0.2% | +45.6% | +4.4% | |
| Feb 9, 2024 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 160,000 | $1.29 | $206,022.87 | +50.3% | +5.9% | +70.4% | |
| Feb 8, 2024 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 120,000 | $1.35 | $162,254.96 | +36.7% | +10.9% | +79.7% | |
| Dec 1, 2023 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Sell | 250 | $1.88 | $469.25 | - | -24.3% | -17.3% | |
| Nov 27, 2023 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Sell | 278 | $1.89 | $525.42 | - | -29.5% | -21.1% | |
| Sep 15, 2023 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 20,000 | $1.60 | $32,000.00 | +6.5% | +18.6% | +1.2% | |
| Sep 7, 2023 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 2,500 | $2.07 | $5,165.00 | +0.8% | -4.3% | -19.0% | |
| Jul 27, 2023 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 1,000 | $2.80 | $2,800.00 | +0.3% | -36.7% | -42.8% | |
| Feb 22, 2023 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 6,200 | $2.86 | $17,705.00 | +2.1% | +110.2% | -55.6% | |
| Sep 23, 2022 | BRTX Biorestorative Therapies, Inc. | 10% Owner | Buy | 300 | $2.83 | $848.97 | +0.1% | +9.8% | -37.7% |